Correction: Elevated carbonic anhydrase-1 in the aqueous humor in diabetic macular edema: associations between inflammatory cytokines and retinal vascular dysfunction - Report - MDSpire
Advertisement
Correction: Elevated carbonic anhydrase-1 in the aqueous humor in diabetic macular edema: associations between inflammatory cytokines and retinal vascular dysfunction
Correction: Increased levels of carbonic anhydrase-1 in aqueous humor
Overview
This report corrects the affiliation and funding statement for the study on carbonic anhydrase-1 levels in diabetic macular edema.
Background
Diabetic macular edema (DME) is a significant complication of diabetes, leading to vision impairment. Understanding biochemical markers associated with DME, such as carbonic anhydrase-1, is important.
Data Highlights
No numerical data or trial results were presented in the correction.
Key Findings
["The authors' affiliation was updated to include the Center for High Altitude Medicine, West China Hospital, Sichuan University.", 'The funding statement was corrected to reflect the financial support received for the study.', 'The study investigates the role of carbonic anhydrase-1 in the aqueous humor of patients with diabetic macular edema.']
Clinical Implications
Clinicians should be aware of the updated affiliations and funding sources when interpreting the findings of the study. Understanding the role of carbonic anhydrase-1 may inform future research directions in managing diabetic macular edema.
Conclusion
This correction emphasizes the importance of accurate reporting in scientific research. The findings related to carbonic anhydrase-1 in diabetic macular edema remain relevant for ongoing studies.
US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.
